PTK2 and small cell lung carcinoma: To determine the role of mTOR/AKT signaling in FAK dependence in certain cell lines, we treated SCLC cell lines with the AKT inhibitor MK-2206 and the mTOR inhibitor Torin 1 and evaluated their impacts on cell proliferation.